The net result of these mechanisms is a self-perpetuating cycle in which obesity-driven inflammation and insulin resistance accelerate muscle catabolism, and low muscle mass in turn worsens metabolic dysfunction—an unhealthy synergy that has been termed “sarcopenic obesity.” Here, INS is linked to Obesity.